Andrew D Cook Selected Research

Cell Surface Receptors

1/2017

G-CSF Receptor Blockade Ameliorates Arthritic Pain and Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew D Cook Research Topics

Disease

16	Arthritis (Polyarthritis) 10/2023 - 01/2010
15	Inflammation (Inflammations) 01/2019 - 04/2004
13	Rheumatoid Arthritis 10/2023 - 03/2002
12	Pain (Aches) 11/2020 - 09/2012
8	Peritonitis 01/2019 - 11/2003
4	Autoimmune Diseases (Autoimmune Disease) 12/2016 - 10/2004
4	Experimental Arthritis 01/2013 - 03/2002
3	Osteoarthritis 01/2018 - 01/2004
3	Neoplasms (Cancer) 12/2016 - 10/2011
3	Disease Progression 01/2016 - 01/2005
3	Pneumonia (Pneumonitis) 07/2015 - 04/2004
2	Necrosis 01/2020 - 02/2018
2	Infections 12/2016 - 04/2004
2	Wounds and Injuries (Trauma) 05/2014 - 01/2010
1	Chronic Pain 11/2020
1	Osteophyte 01/2018
1	Chronic Periodontitis 01/2017
1	Periodontitis 06/2015
1	Neoplasm Metastasis (Metastasis) 08/2014
1	Breast Neoplasms (Breast Cancer) 08/2014
1	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2014
1	Gliosis 05/2014
1	Atrophy 05/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2014
1	Synovitis 09/2012
1	Anorexia 10/2011
1	Cachexia 10/2011
1	Lung Diseases (Lung Disease) 04/2004
1	Psoriatic Arthritis 01/2004

Drug/Important Bio-Agent (IBA)

22	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2023 - 04/2004
13	CytokinesIBA 11/2020 - 10/2004
7	Macrophage Colony-Stimulating FactorIBA 10/2018 - 04/2007
5	ZymosanIBA 01/2020 - 01/2017
5	methylated bovine serum albumin (MBSA)IBA 01/2020 - 11/2003
5	Monoclonal AntibodiesIBA 12/2016 - 08/2011
5	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2015 - 03/2002
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017 - 08/2014
4	AntigensIBA 12/2016 - 01/2010
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2016 - 01/2010
2	GlucocorticoidsIBA 10/2023 - 01/2019
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2020 - 02/2013
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2020 - 02/2013
2	LigandsIBA 01/2020 - 01/2018
2	Tumor Necrosis Factor InhibitorsIBA 01/2019 - 02/2018
2	Collagenases (Collagenase)FDA Link 01/2018 - 09/2012
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2018 - 01/2017
2	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 01/2017 - 08/2014
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016 - 01/2011
2	ChemokinesIBA 01/2016 - 01/2016
2	Fibrinolysin FDA Link 06/2015 - 01/2010
2	Plasminogen Activators (Plasminogen Activator)IBA 06/2015 - 03/2002
2	AntibodiesIBA 08/2014 - 01/2004
2	Neutralizing AntibodiesIBA 08/2014 - 04/2004
2	Matrix Metalloproteinases (MMPs)IBA 09/2012 - 04/2004
2	CollagenIBA 01/2011 - 01/2004
2	LipopolysaccharidesIBA 01/2011 - 04/2004
2	Collagen Type II (Type II Collagen)IBA 01/2010 - 01/2004
2	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2006 - 03/2002
2	FibrinIBA 04/2006 - 03/2002
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 10/2023
1	Conditioned Culture MediaIBA 11/2020
1	Nerve Growth Factor (NGF)IBA 11/2020
1	EicosanoidsIBA 01/2020
1	Interleukin-23 (Interleukin 23)IBA 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	Interleukin-1 (Interleukin 1)IBA 01/2019
1	mavrilimumabIBA 02/2018
1	Biomarkers (Surrogate Marker)IBA 02/2018
1	CCR4 ReceptorsIBA 01/2018
1	InflammasomesIBA 01/2017
1	Cell Surface ReceptorsIBA 01/2017
1	Interleukin-3 (Interleukin 3)IBA 12/2016
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 12/2016
1	Interleukin-6 (Interleukin 6)IBA 12/2016
1	AutoantibodiesIBA 01/2016
1	AutoantigensIBA 01/2016
1	Complement System Proteins (Complement)IBA 01/2016
1	Fc Receptors (Fc Receptor)IBA 01/2016
1	IntegrinsIBA 01/2016
1	PlasminogenIBA 06/2015
1	Nicotinic AgonistsIBA 03/2015
1	Muscarinic AgonistsIBA 03/2015
1	Cholinergic Agents (Cholinergics)IBA 03/2015
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2015
1	Neuroprotective AgentsIBA 05/2014
1	salicylhydroxamic acid (SHAM)IBA 05/2014
1	Freund's AdjuvantIBA 02/2013
1	Cyclooxygenase InhibitorsIBA 02/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2013
1	Messenger RNA (mRNA)IBA 01/2013
1	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 04/2012
1	Proteoglycans (Proteoglycan)IBA 01/2010
1	Histocompatibility Antigens Class IIIBA 01/2010
1	Transcription Factors (Transcription Factor)IBA 04/2007
1	estropipate (Ogen)FDA LinkGeneric 04/2006
1	Irritants (Vesicants)IBA 10/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2004
1	EndotoxinsIBA 04/2004

Therapy/Procedure

7	Therapeutics 01/2019 - 04/2007
1	Investigational Therapies (Experimental Therapy) 02/2018